Frailty and comorbidity burden independently predict higher healthcare costs and nonhome discharges after total shoulder arthroplasty

© 2025 The Author(s).

Bibliographische Detailangaben
Veröffentlicht in:JSES international. - 2020. - 9(2025), 5 vom: 07. Sept., Seite 1698-1704
1. Verfasser: Mayfield, Cory K (VerfasserIn)
Weitere Verfasser: Wier, Julian, Liu, Kevin C, Lin, Eric H, Feingold, Cailan L, Weber, Alexander E, Gamradt, Seth C, Liu, Joseph N, Petrigliano, Frank A
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2025
Zugriff auf das übergeordnete Werk:JSES international
Schlagworte:Journal Article Comorbidity Disposition Frailty Healthcare utilization Optimization Shoulder arthroplasty
LEADER 01000caa a22002652c 4500
001 NLM393646939
003 DE-627
005 20251008232158.0
007 cr uuu---uuuuu
008 251007s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jseint.2025.05.024  |2 doi 
028 5 2 |a pubmed25n1593.xml 
035 |a (DE-627)NLM393646939 
035 |a (NLM)41049654 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Mayfield, Cory K  |e verfasserin  |4 aut 
245 1 0 |a Frailty and comorbidity burden independently predict higher healthcare costs and nonhome discharges after total shoulder arthroplasty 
264 1 |c 2025 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 06.10.2025 
500 |a Date Revised 08.10.2025 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2025 The Author(s). 
520 |a Background: With an aging population, total shoulder arthroplasty (TSA) will more frequently be performed in older adults. Comorbidity burden and frailty are two distinct risk factors for adverse outcomes; however, their independent effect on outcomes after TSA is unknown. The aim of this study was to determine the effect of frailty and comorbidities on postoperative healthcare utilization after TSA 
520 |a Methods: Patients who underwent primary, elective anatomic or reverse TSA between January 1, 2016, and December 31, 2020, were identified using the Premier Healthcare Database. Frailty was defined using the Johns Hopkins Adjusted Clinical Groups Frailty Index. Comorbidity burden was defined via the Elixhauser Comorbidity Index (unhealthy >2 comorbidities). These were then used to define healthy, frail, unhealthy, and frail/unhealthy patients. Rates of protracted (>2 days) length of stay (LOS), skilled nursing facility (SNF) discharges, and readmission were then compared between groups. Multivariable models were conducted to evaluate the adjusted effect of frailty and comorbidity burden 
520 |a Results: 86,356 patients who underwent TSA were identified. 53,913 were categorized as healthy, 29,461 as unhealthy, 1,640 as frail, and 1,342 as frail/unhealthy. The frail/unhealthy cohort had the highest rates of protracted LOS (65.06%), SNF discharges (29.90%), and readmissions (5.00%). The frail cohort had higher rates of protracted LOS (48.96% vs. 39.78%) and SNF discharges (16.77% vs. 9.94%), with similar readmission rates (3.35% vs. 3.18%) when compared to the unhealthy group. These overall trends persisted after accounting for potential confounding factors 
520 |a Conclusion: When both present, frailty and comorbidity appear to be a major driver of increased healthcare utilization after TSA. These data can be used to guide patient expectations and illustrate the need for postoperative pathways for these patients 
650 4 |a Journal Article 
650 4 |a Comorbidity 
650 4 |a Disposition 
650 4 |a Frailty 
650 4 |a Healthcare utilization 
650 4 |a Optimization 
650 4 |a Shoulder arthroplasty 
700 1 |a Wier, Julian  |e verfasserin  |4 aut 
700 1 |a Liu, Kevin C  |e verfasserin  |4 aut 
700 1 |a Lin, Eric H  |e verfasserin  |4 aut 
700 1 |a Feingold, Cailan L  |e verfasserin  |4 aut 
700 1 |a Weber, Alexander E  |e verfasserin  |4 aut 
700 1 |a Gamradt, Seth C  |e verfasserin  |4 aut 
700 1 |a Liu, Joseph N  |e verfasserin  |4 aut 
700 1 |a Petrigliano, Frank A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t JSES international  |d 2020  |g 9(2025), 5 vom: 07. Sept., Seite 1698-1704  |w (DE-627)NLM307818438  |x 2666-6383  |7 nnas 
773 1 8 |g volume:9  |g year:2025  |g number:5  |g day:07  |g month:09  |g pages:1698-1704 
856 4 0 |u http://dx.doi.org/10.1016/j.jseint.2025.05.024  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_50 
912 |a GBV_ILN_65 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 9  |j 2025  |e 5  |b 07  |c 09  |h 1698-1704